Kayentis, a global leader in eCOA and decentralized clinical trial solutions, empowers pharma, biotech and CROs to streamline data collection in clinical trials, enhancing simplicity, efficiency and data quality. Since 2005, Kayentis has spearheaded clinical development, specializing in eCOA solutions across phases I-IV in over 200 indications across more than 20 therapeutic areas. Adapting to the changing landscape, Kayentis is now offering a comprehensive suite of services to support science-driven and patient-centric clinical research, with operational capabilities across the US, Europe and Asia.
Looking for a particular Kayentis employee's phone or email?
The Kayentis annual revenue was $50.7 million in 2026.
Matthieu Plessis is the CFO of Kayentis.
142 people are employed at Kayentis.
Kayentis is based in Meylan, Auvergne-Rhone-Alpes.
The NAICS codes for Kayentis are [325, 32541, 3254, 51, 513, 32].
The SIC codes for Kayentis are [283, 73, 28, 737].